SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs board to consider final dividend

18 May 2012 Evaluate

Vivimed Labs has informed that a meeting of the board of directors of the company will be held on May 30, 2012, to consider the audited financial results for financial year ended March 31, 2012 and to consider recommendation of final dividend for financial year ended March 31, 2012.

The above information is part of company’s filing submitted to the BSE.

Vivimed Labs Share Price

7.38 -0.26 (-3.40%)
21-Apr-2026 12:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×